E
Iovance Biotherapeutics, Inc. IOVA
$2.45 -$0.08-3.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -389.92M -375.36M -372.18M -410.00M -440.22M
Total Depreciation and Amortization 45.84M 44.76M 43.61M 41.63M 40.36M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 100.41M 103.85M 98.15M 77.40M 64.58M
Change in Net Operating Assets -59.74M -107.64M -122.56M -72.69M -53.48M
Cash from Operations -303.41M -334.39M -352.98M -363.65M -388.76M
Capital Expenditure -20.13M -13.11M -11.07M -10.43M -11.72M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 0.00 0.00 -52.57M -52.32M -55.70M
Divestitures -- -- -- -- --
Other Investing Activities 24.71M 44.07M -32.77M -130.18M -155.73M
Cash from Investing 4.59M 30.96M -96.41M -192.93M -223.15M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 214.11M 354.20M 403.52M 401.48M 556.43M
Repurchase of Common Stock -13.31M -13.80M -12.86M -12.16M -6.27M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 200.81M 340.40M 390.66M 389.32M 550.16M
Foreign Exchange rate Adjustments 1.32M 458.00K -541.00K 3.66M 412.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -96.70M 37.43M -59.27M -163.61M -61.33M